Evidence map›Paper›PMID 42755543›Full record

ArticleFrontiers in immunology2026

Diabetes impairs antifungal immunity and drives fatal disseminated sporotrichosis in mice.

Mariana Araujo Oliveira, Ywa Perpétuo Socorro Toda Tavares, Renata Chaves Albuquerque, Silene Migliorini, Sandro Rogério Almeida, Joilson O Martins

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mariana Araujo OliveiraLaboratory of Immunoendocrinology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Ywa Perpétuo Socorro Toda TavaresLaboratory of Immunoendocrinology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Renata Chaves AlbuquerqueLaboratory of Mycology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Silene MiglioriniLaboratory of Immunoendocrinology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Sandro Rogério AlmeidaLaboratory of Mycology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Joilson O MartinsLaboratory of Immunoendocrinology, Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study establishes and characterizes a novel experimental mouse model to evaluate Methods: Diabetic and normoglycemic control mice were infected with Results: Diabetic mice exhibited enhanced susceptibility to infection compared to normoglycemic controls, presenting with progressive ulcerative lesions, systemic dissemination (lymph nodes, liver, and brain), and 100% mortality. This severe phenotype was accompanied by a dysregulated inflammatory profile, characterized by elevated systemic TNF-α, IFN-γ, and IL-6 alongside reduced splenic CD4+ T cell frequencies. Functionally, macrophages from diabetic hosts displayed an initial increase in yeast association followed by a rapid decline, consistent with cellular exhaustion. Additionally, infected diabetic mice exhibited hepatic accumulation of Discussion: Overall, this model successfully reproduces severe, disseminated sporotrichosis under hyperglycemic conditions and delineates the multifaceted immune dysregulation associated with host susceptibility. This novel experimental platform provides a valuable tool for future studies exploring fungal pathogenesis and therapeutic strategies in metabolic comorbidities.

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1SporothrixSporotrichosisAnimalsAutophagyCytokinesDisease Models, AnimalMacrophagesMiceCytokinesantifungal immunityautophagydiabeteshyperglycaemiaSporothrix brasiliensissporotrichosis

Identifiers

PMID42755543
PMCPMC13581713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.